(Q44860591)

English

Recombinant gamma interferon in advanced breast cancer: a phase II trial

scientific article published in January 1986

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Recombinant gamma interferon in advanced breast cancer: a phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

phase II clinical trial

0 references

1

object named as

H B Muss

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

M Caponera

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

P J Zekan

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

D V Jackson

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J J Stuart

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

F Richards

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

M R Cooper

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

E A Levin

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S D Reich

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R L Capizzi

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

377-381

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of recombinant alpha interferon in patients with recurrent or metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of antibody response in patients receiving recombinant Escherichia coli-derived human interferon-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons in the treatment of human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/3108190

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00173511

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44860591&oldid=2206962900"